Jaguar Animal Health Inc (JAGX) is a Healthcare · Biotechnology company listed on NASDAQ. Price $2.71 (-1.45%), Market cap $0.00B, 52-week low–high $0.23 ~ $6.96.
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. Its lead prescription drug is Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer
Financial statements, price targets, institutional (13F) holdings and related news for Jaguar Animal Health Inc are updated in real time on BlackAll Trade.
Jaguar Animal Health Inc trades at $2.71 (-1.45%). Real-time quotes and charts are available on BlackAll Trade.
Jaguar Animal Health Inc has a market cap of about $0.00B.
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two